IWN Stock News Russell 2000 Value Index Ishares (IWN) 96.03 08/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Russell 2000 Value Index Ishares (IWN) 96.03 $IWN

Watch for iShares Russell 2000 Value Index Fund to Potentially Rebound After Falling 1.36% Yesterday
Comtex SmarTrend(R) - Mon Jul 07, 6:25PM CDT
iShares Russell 2000 Value Index Fund (AMEX:IWN) traded in a range yesterday that spanned from a low of $102.25 to a high of $103.58. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $102.92 on volume of 692,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of iShares Russell 2000 Value Index Fund After 1.36% Loss
Comtex SmarTrend(R) - Mon Jul 07, 6:24PM CDT
iShares Russell 2000 Value Index Fund (AMEX:IWN) traded in a range yesterday that spanned from a low of $102.25 to a high of $103.58. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $102.92 on volume of 692,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Notable ETF Inflow Detected - IWN, NRF, ARCP, KATE
ETFChannel.com - Fri Jun 06, 9:50AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 2000 Value ETF where we have detected an approximate $65.4 million dollar inflow -- that's a 1.1%...

SmarTrend Watching for Potential Pullback in Shares of iShares Russell 2000 Value Index Fund After 1.10% Gain
Comtex SmarTrend(R) - Tue Apr 01, 6:00PM CDT
iShares Russell 2000 Value Index Fund (AMEX:IWN) traded in a range yesterday that spanned from a low of $100.95 to a high of $102.13. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $101.12 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 1.10% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Apr 01, 5:59PM CDT
iShares Russell 2000 Value Index Fund (AMEX:IWN) traded in a range yesterday that spanned from a low of $100.95 to a high of $102.13. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $101.12 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Time for This Small Cap Value ETF? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 7:00AM CDT
Should investors look to this value ETF for exposure to small cap stocks?

iShares Russell 2000 Value Index Fund Falls 1.87% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Mar 26, 4:41PM CDT
iShares Russell 2000 Value Index Fund (AMEX:IWN) traded in a range yesterday that spanned from a low of $99.21 to a high of $101.77. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $100.53 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

IWN, NRF, CNO, PB: ETF Outflow Alert
ETFChannel.com - Thu Feb 13, 10:07AM CST
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 2000 Value ETF where we have detected an approximate $114.9 million dollar outflow -- that's a 2.0%...

The Perfect Portfolio Does Not Exist
at The Street - Mon Dec 30, 9:20AM CST
But investors can use ETFs to create a well diversified portfolio that is simple to manage.

A Leverage-Free Version of the Risk Parity Portfolio
at The Street - Fri Dec 27, 8:46AM CST
Concentrating equity exposure in more volatile funds means exposing less of your portfolio to the equity market.

Watch for iShares Russell 2000 Value Index Fund to Potentially Pullback After Gaining 1.09% Yesterday
Comtex SmarTrend(R) - Mon Dec 16, 4:31PM CST
iShares Russell 2000 Value Index Fund (AMEX:IWN) traded in a range yesterday that spanned from a low of $95.87 to a high of $96.75. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $96.63 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Diversified? Think Again
Chad Karnes - ETFG - Wed Jul 31, 6:42PM CDT
The markets have recovered since the 2008 financial crisis making new all time highs. But, your portfolio may not be near as well off as it seems.

After Yesterday's Decline of 2.47%, iShares Russell 2000 Value Index Fund Offers Investors Better Value
Comtex SmarTrend(R) - Wed May 01, 4:29PM CDT
iShares Russell 2000 Value Index Fund (AMEX:IWN) traded in a range yesterday that spanned from a low of $81.69 to a high of $83.64. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $82.27 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 197

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 150

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 303

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 309

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 148

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 108

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 268

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Healthcare Realty Trust's Q4 Highlights and Dividend Update

Updated Category News Views 112

Healthcare Realty Trust Quarterly Results Overview Healthcare Realty Trust Incorporated (NYSE: HR) has reported its fourth quarter results for the year 2024, highlighting significant developments in its operations and financial performance. The company recorded a net (loss) income attributable to common stockholders of $(106.8) million, or $(0.31) per diluted share,...

Continue Reading
BGL's Strategic Move: Selling Western Botanicals to Riverside

Updated Category News Views 322

Brown Gibbons Lang & Company (BGL) has just sealed the deal on a significant sale—Western Botanicals, a prominent player in the Vitamins, Minerals, and Supplements (VMS) contract development and manufacturing space, is headed to The Riverside Company. Now this isn’t just another corporate shuffle; it's BGL’s third foray into the CDMO subsector and marks their fourth...

Continue Reading
High Arctic Energy Services Reports Second Quarter 2025 Success

Updated Category News Views 225

High Arctic Energy Services Reports Strong Second Quarter Results High Arctic Energy Services Inc. (TSX: HWO), a noted energy services provider, has recently shared its financial results for the second quarter of 2025, highlighting a continued commitment to operational excellence amid challenging market conditions. 2025 Second Quarter Performance Overview The company...

Continue Reading
DXC Technology Investors Notified of Securities Class Action

Updated Category News Views 45

DXC Technology Class Action Notice for Shareholders The Gross Law Firm has released an important notice for shareholders of DXC Technology Company (NYSE: DXC). This notice is aimed at individuals who acquired shares during the specified class period. Shareholders are encouraged to reach out to the firm if they are interested in being considered for the role of lead...

Continue Reading
Manulife's $750M US Offering: Risky or Strategic?

Updated Category News Views 50

Manulife: Debuting $750M in Subordinated Notes When it comes to Manulife's latest move, it's all about the numbers. They've priced a U.S. public offering of a meaty $750 million in subordinated notes at an enticing 6.146% interest rate. That's no pocket change, folks, and it highlights a strategy or a gamble, depending on your view. But here's the kicker: these notes may...

Continue Reading